Edited by Shreyasi Asthana March 20, 2025 105 Add to Email Alerts TOPLINE: The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid arthritis (RA). No increase in the risk for RA flares was observed within 30 days following vaccination....
Tag: <span>recmbinant zoster</span>
Post
Two doses of recombinant zoster vaccine highly effective
by Elana Gotkine Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning a little over four years of follow-up, according to a study published online on Jan. 9 in the Annals of Internal Medicine. Ousseny Zerbo, Ph.D., from Kaiser Permanente Northern California...